There are several studies about the NF-κB-94 ins/del polymorphism in neoplastic diseases, which showed that this polymorphism may be associated with the increased risk of epithelial ovarian cancer and oral squamous cell carcinoma [25, 26]. This evidence concerns the gene NFKB1 and ovarian carcinoma.